Dr. Chester Whitley is a pediatrician practicing in Minneapolis, MN. Dr. Whitley is a doctor who specializes in the health care of children. As a pedicatrician, Dr. Whitley diagnoses and treats infections, injuries, diseases and other disorders in children. Pediatricians typically work with infants, children, teenagers and young adults up to age 21. They practice medical care as well as preventative health care. Dr. Whitley can oversee and manage the physical, mental and emotional health of their patients.
Education and Training
Univ of Mn Med Sch-Minneapolis, Minneapolis Mn 1980
University of Mn Med Sch 1980
Medical GeneticsAmerican Board of Medical GeneticsABMG
- Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe.
- Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow.
- Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
- A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.
- Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
- Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.
- Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice
- Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor.
- Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome.
- Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I.
- Age-related functional and histopathological changes of the ear in the MPS I mouse.
- Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses.
- Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase.
- Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.
- Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.
- Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.
- Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I.
- START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients.
- Source document verification in the Mucopolysaccharidosis Type I Registry.
- Lysosomal Disease Network's WORLD Symposium™ 2012.
- High-dose enzyme replacement therapy in murine Hurler syndrome.
- Standardization of α-L-iduronidase enzyme assay with Michaelis-Menten kinetics.
- Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome.
- Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA.
- Phenylketonuria Scientific Review Conference: state of the science and future research needs.
- Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.
- Gene therapy for neurologic manifestations of mucopolysaccharidoses.
- Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses.
- Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale.
- Neurocognition across the spectrum of mucopolysaccharidosis type I: Age,
- Clinical Features of Lysosomal Acid Lipase Deficiency.
- Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants.
- Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction.
- Comorbidities and pharmacotherapies in patients with Gaucher disease type 1: The potential for drug-drug interactions.
- A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.
- Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI.
- Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI.
- A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II.
- Hypothyroidism in late-onset Pompe disease.
- Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I.
- Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional
- WORLDSymposium™ 2017 Introduction.
- Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II.
- Infantile gangliosidoses: Mapping a timeline of clinical changes.
- Correlation between urinary GAG and anti-idursulfase ERT neutralizing antibodies during treatment with NICIT immune tolerance regimen: A case report.
- Phenotype prediction for mucopolysaccharidosis type I by in silico analysis.
- Best Doctors in America 2007-2010
- MemberMinnesota Medical Association/Twin Cities
- Fairview-Univ Med Ctr, Pediatrics
- University of Minnesota Affiliated Hospitals 1981
- University of Minnesota
- University of Minnesota Department of Pediatrics, Genetics 1983
Dr. Chester B Whitley MD's Practice location
Minneapolis, MN 55455Get Direction
Dr. Chester B Whitley MD's reviewsWrite Review
- Why Children Should Avoid Energy Drinks
The American Academy of Pediatrics clearly mentions that children should not drink high-octane energy drinks and should avoid having sports drinks. Energy drinks are unhealthy because of the high content of caffeine and other stimulants present in the drink, according to a report published in,...
- What Are the Symptoms of Chickenpox?
Chickenpox is an infectious disease caused by varicella zoster virus. It is very common among children but may affect adults also. Infection by this virus causes red blisters in different parts of the body. This skin condition has become less common with the advent of chickenpox vaccination. The...
- Children Who Snore May Develop Behavioral Problems
A new study shows that snoring, breathing through one's mouth, and stopping breathing while asleep may lead to behavioral problems in children. Earlier studies have shown that these disorders in sleeping are known as hyperactivity.The study recruited pregnant women who were due to deliver between...
- Raising a Child with Autism
Autism spectrum disorder (ASD), or autism, is a term used to describe a group of complex brain disorders in human beings. These disorders affect the social interaction of a person, verbal skills, nonverbal communication, and repetitive behaviors, along with any activity that needs a person to react...
- What are the Treatment Methods for ADHD?
Reported cases of ADHD have been on the rise lately. In fact, the U.S. Centers for Disease Control and Prevention reported that as many as 11% of children between the ages of four years old and 17 years old have been diagnosed with ADHD. ADHD is a disease characterized by ongoing patterns of...
- Why Are My Eyes Yellow and What Do Yellow Eyes Indicate?
Eyes speak a thousand words. This statement is not just used to describe the beauty of the eyes, but it's even true when it comes to indicating the health of the body. Our eyes can be a clear reflection of how we feel on the inside. White, clear and shiny eyes, as you would see in a baby, indicate...
- Ernest Swihart15729 Woodgate Road South Minnetonka Minnesota 55345
- Dr. Vicki M. Oster MD18315 Cascade Drive Eden Prairie Minnesota 55347
- Dr. Christy S Sanford MD3024 Snelling Ave Minneapolis MN 55406
- Andrea D Singh Other3850 Park Nicollet Blvd Minneapolis MN 55416
- Dr. Jennifer L Lessin M.D.8455 Flying Cloud Dr Eden Prairie MN 55344
- Dr. Julie M Faulkner MD1875 Woodwinds Dr Saint Paul MN 55125